Inflammatory myopathies and human leukocyte antigen

Yuko Ohnuki, Shigeaki Suzuki, Takashi Shiina

Research output: Contribution to journalArticle

Abstract

Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of subacute, chronic or acute systemic immune-mediated diseases of the skeletal muscles. Recently, research has shown the utility of adding new classifications of myopathies, mainly based on their pathology and the presence of specific autoantibodies. In addition, developments in genetics have helped reveal the genetic background of IIM. The human leukocyte antigen genomic region has been consistently shown to be the strongest genetic risk factor for IIM. The present review summarizes the previous and current literature on human leukocyte antigen analysis of IIM, as well as future directions for research.

Original languageEnglish
JournalClinical and Experimental Neuroimmunology
DOIs
Publication statusAccepted/In press - 2017

Keywords

  • Human leukocyte antigen
  • Idiopathic inflammatory myopathy
  • Myositis-specific autoantibodies

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Inflammatory myopathies and human leukocyte antigen'. Together they form a unique fingerprint.

  • Cite this